Catalyst Wire Dossier Catalyst Wire Dossier

Opsumit (Macitentan)

Macitentan · Actelion Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Opsumit (Macitentan), covering 2025-03-30 to 2025-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and Tadalafil [Phase 1]

See pricing